ISELLA, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 7.000
EU - Europa 3.554
AS - Asia 2.360
OC - Oceania 43
SA - Sud America 24
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.007
Nazione #
US - Stati Uniti d'America 6.910
IT - Italia 1.491
CN - Cina 1.384
DE - Germania 310
GB - Regno Unito 268
IE - Irlanda 260
SG - Singapore 257
SE - Svezia 195
JP - Giappone 189
FI - Finlandia 172
FR - Francia 149
AT - Austria 118
IN - India 97
KR - Corea 83
HK - Hong Kong 77
UA - Ucraina 77
PL - Polonia 75
NL - Olanda 74
CA - Canada 72
DK - Danimarca 70
VN - Vietnam 66
BE - Belgio 63
TW - Taiwan 58
ES - Italia 56
ID - Indonesia 54
AU - Australia 37
CH - Svizzera 30
RO - Romania 27
TH - Thailandia 23
RU - Federazione Russa 22
TR - Turchia 18
NO - Norvegia 17
BR - Brasile 16
GR - Grecia 15
IR - Iran 14
MX - Messico 14
CZ - Repubblica Ceca 11
PT - Portogallo 11
IL - Israele 10
MY - Malesia 7
HU - Ungheria 6
NZ - Nuova Zelanda 6
ZA - Sudafrica 6
BA - Bosnia-Erzegovina 5
RS - Serbia 5
UZ - Uzbekistan 5
AL - Albania 4
BN - Brunei Darussalam 4
CL - Cile 4
EG - Egitto 4
LU - Lussemburgo 4
NG - Nigeria 4
PK - Pakistan 4
A1 - Anonimo 3
BG - Bulgaria 3
EU - Europa 3
HR - Croazia 3
SN - Senegal 3
BY - Bielorussia 2
CO - Colombia 2
DM - Dominica 2
EE - Estonia 2
JO - Giordania 2
LK - Sri Lanka 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AM - Armenia 1
AR - Argentina 1
CU - Cuba 1
GE - Georgia 1
HN - Honduras 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
MT - Malta 1
PH - Filippine 1
SI - Slovenia 1
VE - Venezuela 1
Totale 13.007
Città #
Ann Arbor 2.543
Chandler 505
Fairfield 451
Beijing 338
Torino 297
Houston 270
Ashburn 267
Dublin 243
Woodbridge 228
Shanghai 195
Seattle 189
Wilmington 174
Singapore 172
Cambridge 160
Redwood City 135
Turin 130
Vienna 112
Guangzhou 97
Milan 95
Dearborn 86
Pisa 84
Lappeenranta 80
Nyköping 78
Tokyo 72
Genoa 69
Medford 67
New York 59
Princeton 58
Nanjing 56
Eitensheim 48
Jacksonville 48
Jakarta 48
Warsaw 48
Wuhan 46
Hangzhou 44
Villeurbanne 44
San Diego 40
Taipei 37
Brussels 36
Dong Ket 35
Helsinki 33
Rome 32
Amsterdam 31
Boardman 31
Los Angeles 31
Fremont 29
Changsha 27
Hong Kong 27
Boston 26
Munich 26
Nanchang 24
Shenyang 24
Zhengzhou 24
Naples 23
London 22
Toronto 22
Chengdu 20
Paris 20
Bangkok 19
Belfast 18
Fuzhou 18
Norwalk 18
Seoul 18
Berlin 17
Carrara 17
Florence 17
Xian 17
Hyderabad 16
Santa Clara 16
Chongqing 15
Phoenix 15
Bologna 13
Jinan 13
Ottawa 13
Bengaluru 12
Harbin 12
Heidelberg 12
Moscow 12
Oslo 12
Pittsburgh 12
Verona 12
Washington 12
Central District 11
Luni 11
Melbourne 11
Tianjin 11
Central 10
Changchun 10
Falls Church 10
Frankfurt am Main 10
Leiden 10
Padova 10
Polska 10
San Francisco 10
Shenzhen 10
Upper Marlboro 10
Buffalo 9
Cagliari 9
Edinburgh 9
Hefei 9
Totale 8.792
Nome #
Stromal contribution to the colorectal cancer transcriptome. 1.862
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. 713
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer 655
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 633
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology 563
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets 490
MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. 383
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 329
Patient-derived xenografts and matched cell lines identify pharmacogenomic vulnerabilities in colorectal cancer 325
MicroRNA–mRNA interactions underlying colorectal cancer molecular subtypes 293
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 284
The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer. 246
Truncated RAF kinases drive resistance to MET inhibition in MET-addicted cancer cells. 235
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 233
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 232
Transcriptional hallmarks of noonan syndrome and noonan-like syndrome with loose anagen hair 221
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis 220
Analisi del profilo di trascrizione genetica nella sindrome di Noonan. 218
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits 213
Evolving neoantigen profiles in colorectal cancers with DNA repair defects 201
High USP6NL levels in breast cancer sustain chronic AKT phosphorylation and GLUT1 stability fueling aerobic glycolysis 199
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin 197
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer. 189
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies 185
Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies 184
Exploiting orthologue diversity for systematic detection of gain-of-functionphenotypes 175
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts 175
A regulatory microRNA network controls endothelial cell phenotypic switch during sprouting angiogenesis 174
A molecularly annotated model of patient-derived colon cancer stem-like cells to assess genetic and non-genetic mechanisms of resistance to anti-EGFR therapy 172
Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature 169
Mulcom: a multiple comparison statistical test for microarray data in Bioconductor 169
FOXA1 and AR in invasive breast cancer: New findings on their co-expression and impact on prognosis in ER-positive patients 163
Transcriptional hallmarks of Noonan syndrome in peripheral blood mononuclear cells 156
Patient-derived xenografts (PDXs) as model systems for human cancer 153
TNF-α promotes invasive growth through the MET signaling pathway. 152
Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers 142
MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer. 141
Pazopanib and trametinib as a synergistic strategy against osteosarcoma: Preclinical activity and molecular insights 136
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies 135
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles 134
Molecular dissection of Noonan syndrome by transcriptiome analysis 127
A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis. 124
Transcriptional signature of Pseudomyxoma Peritonei: An enhancement of treatment strategy and outcome prediction 114
The miR-126 regulates Angiopoietin-1 signaling and vessel maturation by targeting p85β 110
Reverse signaling by semaphorin 4C elicits SMAD1/5- And ID1/3-dependent invasive reprogramming in cancer cells 100
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 92
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination 88
Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power 88
The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. 86
Mek inhibition in a newborn with raf1-associated noonan syndrome ameliorates hypertrophic cardiomyopathy but is insufficient to revert pulmonary vascular disease 77
A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine 65
Synthetic lethality screening highlights colorectal cancer vulnerability to concomitant blockade of nedd8 and egfr pathways 63
The EurOPDX Data Portal: an open platform for patient-derived cancer xenograft data sharing and visualization 43
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas 41
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway 41
Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity 29
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer 28
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer 25
Dual VEGFA/BRAF targeting boosts PD-1 blockade in melanoma through GM-CSF-mediated infiltration of M1 macrophages 23
Machine learning for RNA sequencing-based intrinsic subtyping of breast cancer 21
PO-050 A molecularly annotated platform of pdx-derived cell lines mirrors the genomic landscape of colorectal cancer 13
Abstract 3998: Preclinical efficacy of a synthetic Notch-based combinatorial immunotherapy against colorectal cancer with HER2 amplification 13
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification 11
Abstract LB-299: A comprehensive platform of patient-derived xenografts and matched cell lines mirrors the genomic landscape of colorectal cancer 10
Totale 13.281
Categoria #
all - tutte 28.687
article - articoli 0
book - libri 0
conference - conferenze 1.336
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.023


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.311 0 0 0 208 118 194 149 145 172 135 109 81
2020/20211.852 92 124 174 118 118 119 172 107 138 194 113 383
2021/20223.683 418 360 346 387 303 322 407 334 210 121 281 194
2022/20231.759 167 130 54 151 152 346 108 165 213 50 121 102
2023/20241.447 131 137 92 120 97 146 93 162 39 168 142 120
2024/2025419 87 114 181 37 0 0 0 0 0 0 0 0
Totale 13.281